A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

September 29, 2024

Study Completion Date

September 29, 2024

Conditions

Healthy Volunteer

Interventions

DRUG

Moxifloxacin Oral Tablet

400mg per tablet

DRUG

Omadacycline Oral Tablet

150 mg per tablet

Trial Locations (1)

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Zai Lab (Hong Kong), Ltd.

INDUSTRY

NCT06462326 - A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter